Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 8/2018

01-08-2018 | Letter to the Editor

Diffuse large B cell lymphoma (DLBCL): bilateral vanishing tibiae

Authors: Reinhard Marks, Monika Engelhardt, Sven Hager, Hannah Füllgraf, Norbert P. Südkamp, Georg W. Herget

Published in: Annals of Hematology | Issue 8/2018

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet P, Müller-Quernheim J (2014) Sarcoidosis. Lancet 383:1155–1167CrossRefPubMed
2.
Sparks JA, McSparron JI, Shah N, Aliabadi P, Paulson V, Fanta CH, Coblyn JS (2014) Osseous sarcoidosis: clinical characteristics, treatment, and outcomes—experience from a large, academic hospital. Semin Arthritis Rheum 44:371–379CrossRefPubMed
3.
Chiappella A, Castellino A, Nicolosi M, Santambrogio E, Vitolo U (2017) Diffuse large B-cell lymphoma in the elderly: standard treatment and new perspectives. Expert Rev Hematol 10(4):289–297CrossRefPubMed
4.
Freeman C, Berg JW, Cutler SJ (1972) Occurrence and prognosis of extranodal lymphomas. Cancer 29:252–260CrossRefPubMed
5.
Chang H, Hung YS, Lin TL, Wang PN, Kuo MC, Tang TC, Wu JH, Dunn P, Shih LY (2011) Primary bone marrow diffuse large B cell lymphoma: a case series and review. Ann Hematol 90(7):791–796CrossRefPubMed
6.
Bhagat P, Sachdeva MU, Sharma P, Naseem S, Ahluwalia J, Das R, Varma N, Law A, Malhotra P (2016) Primary bone marrow lymphoma is a rare neoplasm with poor outcome: case series from single tertiary care centre and review of literature. Hematol Oncol 34(1):42–48CrossRefPubMed
7.
Giardino AA, Shinagare AB, Shinagare SA, Dewar R, Weckstein D, Mauch P, Ramaiya NH, Freedman AS (2012) Primary bone lymphoma involving bilateral tibia. Am J Hematol 87(9):924–925CrossRefPubMed
8.
Roukens A, Vlasveld T, Veelken H, Kersting S (2013) Vanishing ulnae: symmetrical diffuse large B-cell lymphoma. Lancet 382(9908):e40CrossRefPubMed
9.
10.
Tachibana A, Robinson RJ, Patel CN (2015) 18F-FDG PET/CT demonstrating primary bone lymphoma of the extremities mimicking an inflammatory peripheral arthropathy. Clin Nucl Med 40(2):169–171CrossRefPubMed
11.
Strüßmann T, Fritsch K, Baumgarten A, Fietz T, Engelhardt M, Mertelsmann R, Ihorst G, Duyster J, Finke J, Marks R (2017) Favourable outcomes of poor prognosis diffuse large B-cell lymphoma patients treated with dose-dense rituximab, high-dose methotrexate and six cycles of CHOP-14 compared to first-line autologous transplantation. Br J Haematol 178(6):927–935CrossRefPubMed
12.
Engelhardt M, Selder R, Pandurevic M, Möller M, Ihorst G, Waldschmidt J, Herget G, Wäsch R (2017) Multidisciplinary tumor boards: facts and satisfaction analysis of an indispensable Comprehensive Cancer Center instrument. Dtsch Med Wochenschr 142(9):e51–e60CrossRefPubMed
Metadata
Title
Diffuse large B cell lymphoma (DLBCL): bilateral vanishing tibiae
Authors
Reinhard Marks
Monika Engelhardt
Sven Hager
Hannah Füllgraf
Norbert P. Südkamp
Georg W. Herget
Publication date
01-08-2018
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 8/2018
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-018-3308-7

Other articles of this Issue 8/2018

Annals of Hematology 8/2018 Go to the issue

Original Article

Outcomes of switching to dasatinib after imatinib-related low-grade adverse events in patients with chronic myeloid leukemia in chronic phase: the DASPERSE study

Original Article

BAALC and ERG expression levels at diagnosis have no prognosis impact on acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation

Letter to the Editor

Large granular lymphocytic leukemia-associated peripheral neuropathy

Letter to the Editor

Clinical impact of underweight status at diagnosis on elderly patients with acute myeloid leukemia: a retrospective study of JALSG GML200

Original Article

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

Review Article

Treatment of classical Hodgkin lymphoma in the era of brentuximab vedotin and immune checkpoint inhibitors
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits